Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Wiener Klinische Wochenschrift|May 23, 1997
Single-dose pharmacokinetics of teicoplanin during hemodialysis therapy using high-flux polysulfone membranesF Thalhammer, A R Rosenkranz, H Burgmann, et al.Blood|November 15, 1995
Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significanceJ Drach, J Angerler, J Schuster, et al.International Journal of Clinical Pharmacology and Therapeutics|November 2, 2004
Pharmacokinetics of teicoplanin during continuous hemofiltration with a new and a 24-h used highly permeable membrane: rationale for therapeutic drug monitoring-guided dosageB Meyer, F Traunmüller, A Hamwi, et al.The Journal of Antimicrobial Chemotherapy|June 1, 1999
Continuous infusion versus intermittent administration of meropenem in critically ill patientsF Thalhammer, F Traunmüller, I El Menyawi, et al.Leukemia Research|March 15, 2001
Prognostic value of lactate dehydrogenase activity in myelodysplastic syndromesF Wimazal, W R Sperr, M Kundi, et al.Annals of Hematology|July 12, 2001
Survival analysis and AML development in patients with de novo myelodysplastic syndromes: comparison of six different prognostic scoring systemsW R Sperr, F Wimazal, M Kundi, et al.European Journal of Clinical Investigation|August 31, 2007
Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapyK J Aichberger, S Herndlhofer, H Agis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Competitive CBFbeta/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion(16): a pilot studyK Laczika, M Novak, B Hilgarth, et al.Blood|July 15, 1997
Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia--a randomized phase-III studyK Geissler, E Koller, E Hubmann, et al.Leukemia|March 23, 1999
Post-transplant acute myeloid leukemia (PT-AML)R Thalhammer-Scherrer, G Wieselthaler, P Knoebl, et al.Pageof 4